Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Contemporary Clinical Trials Communications|January 25, 2021
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocolDavid Pryor, Mathias Bressel, Nathan Lawrentschuk, et al.Cancer Medicine|May 19, 2025
Trends in Practice Patterns and Clinical Outcomes for Desmoid Tumors: A Large Single-Institutional Australian CohortJoseph Sia, Stephanie Tan, Narayan Mohanakrishnan, et al.Practical Radiation Oncology|November 26, 2019
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)Andrew Oar, Mark Lee, Hien Le, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL StudyCristian Udovicich, Mathias Bressel, Jamil Manji, et al.European Urology|December 26, 2021
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT TrialShankar Siva, Mathias Bressel, Simon T Wood, et al.The Lancet. Oncology|May 17, 2026
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trialsShankar Siva, Muhammad Ali, Nicholas Hardcastle, et al.European Urology|July 24, 2019
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal RadiotherapyElise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al.Pageof 6